当前位置:首页 - 行情中心 - 云南白药(000538) - 财务分析 - 现金流量表

云南白药

(000538)

  

流通市值:1024.84亿  总市值:1033.45亿
流通股本:17.69亿   总股本:17.84亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金32,371,993,045.3922,091,374,463.959,848,509,304.4840,638,627,018.49
收到的税费返还8,177,680.735,182,541.295,182,541.294,858,426.21
收到其他与经营活动有关的现金492,241,373.25355,397,604.71179,911,280.63689,121,507.54
经营活动现金流入的平衡项目0000
经营活动现金流入小计32,872,412,099.3722,451,954,609.9510,033,603,126.441,332,606,952.24
购买商品、接受劳务支付的现金22,838,082,887.6315,211,108,311.767,507,610,87529,797,492,545.65
支付给职工以及为职工支付的现金2,106,698,168.921,450,599,844.7883,335,739.832,585,937,678.63
支付的各项税费1,835,654,339.611,217,056,511.47483,059,136.062,465,312,635.54
支付其他与经营活动有关的现金2,018,837,957.871,311,572,550.03632,537,570.532,981,121,744.4
经营活动现金流出的平衡项目0000
经营活动现金流出小计28,799,273,354.0319,190,337,217.969,506,543,321.4237,829,864,604.22
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额4,073,138,745.343,261,617,391.99527,059,804.983,502,742,348.02
二、投资活动产生的现金流量:
收回投资收到的现金3,145,988.513,145,988.513,318,460.152,558,487,934.5
取得投资收益收到的现金406,901,106.8669,197,636.3722,572,997.11436,150,493.91
处置固定资产、无形资产和其他长期资产收回的现金净额2,812,871262,565.3985,392282,170.75
收到的其他与投资活动有关的现金4,713,006,5003,807,040,5002,442,140,5001,978,176,523.1
投资活动现金流入的平衡项目0000
投资活动现金流入小计5,125,866,466.373,879,646,690.272,468,117,349.264,973,097,122.26
购建固定资产、无形资产和其他长期资产支付的现金446,401,375.38248,334,378.5996,602,547.9575,507,137.9
投资支付的现金1,400,000,000900,000,000-73,700,000
支付其他与投资活动有关的现金4,437,259,704.22,936,895,0001,106,883,8163,805,309,321.72
投资活动现金流出的平衡项目0000
投资活动现金流出小计6,283,661,079.584,085,229,378.591,203,486,363.94,454,516,459.62
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,157,794,613.21-205,582,688.321,264,630,985.36518,580,662.64
三、筹资活动产生的现金流量:
吸收投资收到的现金---2,670,000
其中:子公司吸收少数股东投资收到的现金---2,670,000
取得借款收到的现金1,486,779,951.021,486,779,951.021,326,507,043.681,376,188,273.49
收到其他与筹资活动有关的现金51,565,263.7340,525,603.23--
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,538,345,214.751,527,305,554.251,326,507,043.681,378,858,273.49
偿还债务支付的现金1,340,965,842.21869,283,674.87505,591,738.951,424,233,267.77
分配股利、利润或偿付利息支付的现金3,744,008,284.963,731,518,655.9711,494,131.322,767,483,369.05
其中:子公司支付给少数股东的股利、利润-5,974,218.23-19,857,165.96
支付其他与筹资活动有关的现金115,066,565.0972,018,152.3819,376,625.29105,183,876.26
筹资活动现金流出平衡项目0000
筹资活动现金流出小计5,200,040,692.264,672,820,483.22536,462,495.564,296,900,513.08
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-3,661,695,477.51-3,145,514,928.97790,044,548.12-2,918,042,239.59
四、汇率变动对现金及现金等价物的影响-2,606,865.09-48,577.76-969,012.352,324,684.95
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-748,958,210.47-89,528,803.062,580,766,326.111,105,605,456.02
加:期初现金及现金等价物余额14,151,765,468.4914,151,765,468.4914,151,765,468.4913,046,160,012.47
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额13,402,807,258.0214,062,236,665.4316,732,531,794.614,151,765,468.49
补充资料:
净利润-3,189,962,850.96-4,122,561,096.49
资产减值准备-86,340,929.65-194,582,766.59
固定资产和投资性房地产折旧-103,037,172.29-208,456,263.24
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-103,037,172.29-208,456,263.24
无形资产摊销-12,159,001.35-30,940,993.27
长期待摊费用摊销-19,405,792.34-33,493,659.88
处置固定资产、无形资产和其他长期资产的损失-1,592,134.63-79,370.88
固定资产报废损失-65,952.25-10,575,067.5
公允价值变动损失--4,596,876.81--123,566,330.46
财务费用-27,648,907.91-49,601,252.93
投资损失--477,498,314.49--779,010,728.82
递延所得税--90,787,456.62--929,594.85
其中:递延所得税资产减少--107,322,722.98-22,377,570.54
递延所得税负债增加-16,535,266.36--23,307,165.39
存货的减少-450,556,841.55-1,539,521,695.37
经营性应收项目的减少--739,995,094.96--2,088,116,474.45
经营性应付项目的增加-623,860,555.14-198,990,559.88
其他-17,450,377.13-5,257,571.82
现金的期末余额-14,062,236,665.43-14,151,765,468.49
减:现金的期初余额-14,151,765,468.49-13,046,160,012.47
公告日期2024-10-302024-08-272024-04-272024-03-30
审计意见(境内)标准无保留意见
TOP↑